Emerging Paradigms in Type 2 Immunity.

Hammad, Hamida; Debeuf, Nincy; Aegerter, Helena; Brown, Andrew S; Lambrecht, Bart N

Hammad, Hamida; Debeuf, Nincy; Aegerter, Helena; Brown, Andrew S; Lambrecht, Bart N.

Afiliación

Hammad H; Laboratory of Mucosal Immunology and Immunoregulation, VIB-UGent Center for Inflammation Research, Ghent, Belgium; email: hamida.hammad@ugent.be.
Debeuf N; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Aegerter H; Laboratory of Mucosal Immunology and Immunoregulation, VIB-UGent Center for Inflammation Research, Ghent, Belgium; email: hamida.hammad@ugent.be.
Brown AS; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Lambrecht BN; Laboratory of Mucosal Immunology and Immunoregulation, VIB-UGent Center for Inflammation Research, Ghent, Belgium; email: hamida.hammad@ugent.be.

Annu Rev Immunol ; 40: 443-467, 2022 04 26.

Article en En | MEDLINE | ID: mdl-35471837

Asunto(s)

COVID-19; Hipersensibilidad; Animales; Citocinas/metabolismo; Homeostasis; Humanos; Linfocitos T Colaboradores-Inductores/metabolismo; Células Th2

Palabras clave

cancer; metabolism; neuroimmune interactions; respiratory viruses; type 2 immunity

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Hipersensibilidad Límite: Animals / Humans Idioma: En Revista: Annu Rev Immunol Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google